Candidate genes for COPD in two large data sets

European Respiratory Journal

Volumn 37, Issue 2, 2011, Pages 255-263

  Bakke, P S ^a   Zhu, G ^b   Gulsvik, A ^a   Kong, X ^b   Agusti, A G N ^c   Calverley, P M A ^d   Donner, C F ^e   Levy, R D ^f   Make, B J ^g   Pare P D ^g   Rennard, S I ^h   Vestbo, J ^i,j   Wouters, E F M ^k   Anderson, W ^b   Lomas, D A ^l   Silverman, E K ^m   Pillai, S G ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b GLAXOSMITHKLINE   (United States)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e IRCCS   (Italy)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^g NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^h UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

ⁱ HVIDOVRE HOSPITAL   (Denmark)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

^k MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^m BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

Chronic obstructive pulmonary disease; Genetic association; Replication; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE P1; HEME OXYGENASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 5; I KAPPA B KINASE BETA; INTERLEUKIN 11; JANUS KINASE 3; SIRTUIN 2; STAT1 PROTEIN; VITAMIN D BINDING PROTEIN; VOLTAGE GATED POTASSIUM CHANNEL;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GC GENE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NFKBIB GENE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE TRAIT; SINGLE NUCLEOTIDE POLYMORPHISM; SIRT2 GENE; STAT1 GENE;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NORWAY; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SIRTUIN 2; SMOKING; STAT1 TRANSCRIPTION FACTOR; VITAMIN D-BINDING PROTEIN;

EID: 79953651813     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00091709     Document Type: Article

References (41)

1. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750. (Pubitemid 47321907)
2. Lopez AD, Mathers CD, Ezzati M, et al. Global Burden of Disease and Risk Factors. Washington, The World Bank, 2006.
3. Hersh CP, Demeo DL, Lazarus R, et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 977-984.
4. Seifart C, Plagens A. Genetics of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007; 2: 541-550.
5. Ganrot PO, Laurell CB, Erikson S. Obstructive lung disease and trypsin inhibitors in alpha-1-antitrypsin deficiency. Scand J Clin Lab Invest 1967; 19: 205-208.
6. Hersh CP, Demeo DL, Lange C, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33: 71-78. (Pubitemid 40961016)
7. Hall IP, Blakey JD. Genetic association studies in Thorax. A guide to assessing the validity of genetic association studies in respiratory disease. Thorax 2005; 60: 357-359.
8. Zhu G, Warren L, Aponte J, et al. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two populations. Am J Respir Crit Care Med 2007; 176: 167-173. (Pubitemid 47057853)
9. Johannessen A, Omenaas ER, Eide GE, et al. Feasible and simple exclusion criteria for pulmonary reference populations. Thorax 2007; 62: 792-798.
10. Patel BD, Coxson HO, Pillai SG, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 500-505.
11. International HapMap Project. www.hapmap.org Date last accessed: January 31, 2008. Date last updated: August 18, 2010.
12. Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5: e1000421.
13. Lange C, DeMeo D, Silverman EK, et al. PBAT: tools for family-based association studies. Am J Hum Genet 2004; 74: 367-369. (Pubitemid 38168624)
14. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998; 63: 259-266. (Pubitemid 30428342)
15. Horvath S, Xu X, Lake SL, et al. Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics. Genet Epidemiol 2004; 26: 61-69. (Pubitemid 38036644)
16. Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434. (Pubitemid 34112296)
17. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
18. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229. (Pubitemid 34680308)
19. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004; 350: 2645-2653. (Pubitemid 38787999)
20. Saetta M, Mariani M, Panina-Bordignon P, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165: 1404-1409. (Pubitemid 34522945)
21. Tudhope SJ, Cartley MC, Fenwick PS, et al. The role of IkB kinase 2, but not activation of NF-κB, in the release of CXCR3 ligands from IFN-γ-stimulated human bronchial epithelial cells. J Immunol 2007; 179: 6237-6245.
22. Hattotuwa KL, Gizycki MJ, Ansari TW, et al. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med 2002; 165: 1592-1596. (Pubitemid 34693937)
23. Chapman SJ, Khor CC, Vannberg FO, et al. IkB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med 2007; 176: 181-187. (Pubitemid 47057855)
24. Rajendrasozhan S, Yang SR, Kinnula VL, et al. SIRT1, an anti-inflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Dis 2008; 177: 861-870. (Pubitemid 351600664)
25. Outeiro TF, Kontopoulos E, Altmann SM, et al. Sirtuin 2 inhibitors rescue a-synuclein-mediated toxicity in models of Parkinson's disease. Science 2007; 317: 516-519. (Pubitemid 47196116)
26. North BJ, Marshall BL, Borra MT, et al. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003; 11: 437-444. (Pubitemid 36293837)
27. Milne JC, Denu JM. The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opon Chem Biol 2008; 12: 11-17.
28. Daiger SP, Schanfield MS, Cavalli-Sforza LL. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 1975; 72: 2076-2080.
29. Speeckaert M, Huang G, Delanghe JR, et al. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 2006; 372: 33-42. (Pubitemid 44286753)
30. Horne SL, Cockcroft DW, Dosman JA. Possible protective effect against chronic obstructive airways disease by the GC2 allele. Hum Hered 1990; 40: 173-176. (Pubitemid 20171005)
31. Ito I, Nagai S, Hoshino Y, et al. Risk and severity of COPD is associated with the group-specific component of serum globulin1F allele. Chest 2004; 125: 63-70. (Pubitemid 38114565)
32. Ishii T, Keicho N, Teramoto S, et al. Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J 2001; 18: 753-757. (Pubitemid 33076915)
33. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest 2005; 128: 3792-3798. (Pubitemid 43062638)
34. Celli BR. Roger S. Mitchell lecture. Chronic obstructive pulmonary disease phenotypes and clinical relevance. Proc Am Thorac Soc 2006; 3: 461-465.
35. Skorge TD, Eagan TM, Eide GE, et al. The adult incidence of asthma and respiratory symptoms by passive smoking in uterus or in childhood. Am J Respir Crit Care Med 2005; 172: 61-65.
36. Silverman EK, Palmer LJ. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 2000; 22: 645-648. (Pubitemid 30400241)
37. Rothman KJ, Greenland S. Precision and validity in epidemiological studies. In: Rothman KJ, Greenland S, eds. Modern Epidemiology. Philadelphia, Lippincott-Raven, 1998; pp. 115-134.
38. Bakke PS. Designing studies for diagnostic tests. Clin Respir J 2008; 2: 72-75.
39. Molfino N. Current thinking on genetics of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2007; 13: 107-113. (Pubitemid 46175106)
40. Roeder K, Bacanu SA, Sonpar V, et al. Analysis of single-locus tests to detect gene/disease associations. Genet Epidemiol 2005; 28: 207-219. (Pubitemid 40404575)
41. Webster PM, Lorimer EG, Man SF, et al. Pulmonary function in identical twins: comparison of nonsmokers and smokers. Am Rev Respir Dis 1979; 119: 223-228.